Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYP2D6 genotype' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 18 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Catalano, M
      Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    2. Roh, HK; Chung, JY; Oh, DY; Park, CS; Svensson, JO; Dahl, ML; Bertilsson, L
      Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. Lam, LCW; Garcia-Barcelo, MM; Ungvari, GS; Tang, WK; Lam, VKL; Kwong, SL; Lau, BST; Kwong, PPK; Waye, MMY; Chiu, HFK
      Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients

      PHARMACOPSYCHIATRY
    4. Schulze, TG; Schumacher, J; Muller, DJ; Krauss, H; Alfter, D; Maroldt, A; Ahle, G; Maroldt, AO; Fernandez, ANY; Weber, T; Held, T; Propping, P; Maier, W; Nothen, MM; Rietschel, M
      Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and Tardive dyskinesia in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    5. Basile, VS; Ozdemir, V; Masellis, M; Walker, ML; Heltzer, HY; Lieberman, JA; Potkin, SG; Alva, G; Kalow, W; Macciardi, FM; Kennedy, JL
      A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    6. Hori, H; Ohmori, O; Shinkai, T; Kojima, H; Okano, C; Suzuki, T; Nakamura, J
      Manganese superoxide dismutase gene polymorphism and schizophrenia: Relation to tardive dyskinesia

      NEUROPSYCHOPHARMACOLOGY
    7. Dahl, ML; Sjoqvist, F
      Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics

      THERAPEUTIC DRUG MONITORING
    8. Fukuda, T; Yamamoto, I; Nishida, Y; Zhou, Q; Ohno, M; Takada, K; Azuma, J
      Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    9. Ohmori, O; Kojima, H; Shinkai, T; Terao, T; Suzuki, T; Abe, K
      Genetic association analysis between CYP2D6*2 allele and tardive dyskinesia in schizophrenic patients

      PSYCHIATRY RESEARCH
    10. Catalano, M
      The challenges of psychopharmacogenetics

      AMERICAN JOURNAL OF HUMAN GENETICS
    11. Scordo, MG; Spina, E; Facciola, G; Avenoso, A; Johansson, I; Dahl, ML
      Cytochrome P450 2D6 genotype and steady state plasma levels of risperidoneand 9-hydroxyrisperidone

      PSYCHOPHARMACOLOGY
    12. Furukori, H; Kondo, T; Yasui, N; Otani, K; Tokinaga, N; Nagashima, U; Kaneko, S; Inoue, Y
      Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients

      PSYCHOPHARMACOLOGY
    13. SUZUKI A; OTANI K; MIHARA K; YASUI N; KONDO T; TOKINAGA N; FURUKORI H; KANEKO S; INOUE Y; HAYASHI K
      EFFECTS OF VARIOUS FACTORS INCLUDING THE CYP2D6 GENOTYPE AND COADMINISTRATION OF FLUNITRAZEPAM ON THE STEADY-STATE PLASMA-CONCENTRATIONS OFBROMPERIDOL AND ITS REDUCED METABOLITE

      Psychopharmacology
    14. SUZUKI A; OTANI K; MIHARA K; YASUI N; KANEKO S; INOUE Y; HAYASHI K
      EFFECTS OF THE CYP2D6 GENOTYPE ON THE STEADY-STATE PLASMA-CONCENTRATIONS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN JAPANESE SCHIZOPHRENIC-PATIENTS

      Pharmacogenetics
    15. MIHARA K; OTANI K; SUZUKI A; YASUI N; NAKANO H; MENG XM; OHKUBO T; NAGASAKI T; KANEKO S; TSUCHIDA S; SUGAWARA K; GONZALEZ FJ
      RELATIONSHIP BETWEEN THE CYP2D6 GENOTYPE AND THE STEADY-STATE PLASMA-CONCENTRATIONS OF TRAZODONE AND ITS ACTIVE METABOLITE M-CHLOROPHENYLPIPERAZINE

      Psychopharmacology
    16. ANDREASSEN OA; MACEWAN T; GULBRANDSEN AK; MCCREADIE RG; STEEN VM
      NONFUNCTIONAL CYP2D6 ALLELES AND RISK FOR NEUROLEPTICS-INDUCED MOVEMENT-DISORDERS IN SCHIZOPHRENIC-PATIENTS

      Psychopharmacology
    17. DAHL ML; BERTILSSON L; NORDIN C
      STEADY-STATE PLASMA-LEVELS OF NORTRIPTYLINE AND ITS 1.0-HYDROXY METABOLITE - RELATIONSHIP TO THE CYP2D6 GENOTYPE

      Psychopharmacology
    18. NYBERG S; DAHL ML; HALLDIN C
      A PET STUDY OF D-2, AND 5-HT2, RECEPTOR OCCUPANCY INDUCED BY RISPERIDONE IN POOR METABOLIZERS OF DEBRISOQUIN AND RISPERIDONE

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 12:16:18